Publications

  1. Tsang M, Hampel PJ, Rabe KG, Brieghel C, Ding W, Leis JF, Hilal T, Kenderian SS, Wang Y, Muchtar E, Koehler AB, Van Dyke DL, Hanson CA, Shi M, Slager SL, Kay NE, Hjalgrim H, Niemann CU, Parikh SA, Rotbain EC. Comparison of Frontline Therapies in Older Adults Age >/= 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study. Am J Hematol. 2025 Jun 18.
    View PubMed
  2. Hampel PJ, Rabe KG, Wang Y, Hwang SR, Kenderian SS, Muchtar E, Leis JF, Koehler AB, Tsang M, Hilal T, Parrondo R, Bailen RJ, Schwager SM, Hanson CA, Braggio E, Slager SL, Shi M, Zepeda-Mendoza CJ, Van Dyke DL, Shanafelt TD, King RL, Call TG, Kay NE, Ding W, Parikh SA. Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era. Leukemia. 2025 Feb; 39 (2):503-507 Epub 2024 Dec 10
    View PubMed
  3. Filippova GN, Casad M, Groneck C, Hui K, Mishra S, MacDonald JW, Bammler T, Van Dyke DL, Skakkebaek A, Gravholt CH, Mathieu J, Deng X, Berletch JB, Jayadev S, Disteche CM, Young JE. Basic Science and Pathogenesis. Alzheimers Dement. 2024 Dec; 20 Suppl 1:e093548
    View PubMed
  4. Wiedmeier-Nutor JE, McCabe CE, O'Brien DR, Jessen E, Bonolo de Campos C, Boddicker NJ, Griffin R, Allmer C, Rabe KG, Cerhan JR, Parikh SA, Kay NE, Yan H, Van Dyke DL, Slager SL, Braggio E. Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers (Basel). 2024 Jul 3; 16 (13) Epub 2024 July 03
    View PubMed
  5. Wang H, Tian S, Secreto CR, Sinha S, Shi M, Call T, Wang Y, Parikh SA, Kenderian SS, He R, Leis JF, VanDyke DL, Klee EW, Slager SL, Braggio E, Yan H, Ding W. Clonal dynamics of Richter transformation in chronic lymphocytic leukemia. Hematol Oncol 2024 Jul; 42 (4):e3282
    View PubMed
  6. Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL. Blood Adv. 2023 Jul 11; 7 (13):3169-3179
    View PubMed
  7. Gagnon MF, Berg HE, Meyer RG, Sukov WR, Van Dyke DL, Jenkins RB, Greipp PT, Thorland EC, Hoppman NL, Xu X, Baughn LB, Reichard KK, Ketterling RP, Peterson JF. Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies. Genes Chromosomes Cancer. 2022 Oct; 61 (10):629-634 Epub 2022 June 10
    View PubMed
  8. Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA, Kenderian SS, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib. Blood Cancer J. 2022 Sep 1; 12 (9):124 Epub 2022 Sept 01
    View PubMed
  9. Kay NE, Hampel PJ, Van Dyke DL, Parikh SA. CLL update 2022: A continuing evolution in care. Blood Rev. 2022 Jul; 54:100930 Epub 2022 Jan 26
    View PubMed
  10. Wang H, Tian S, Zhao Q, Blumenschein W, Yearley JH, Secreto CR, Sinha S, Call TG, Wang Y, Parikh SA, Kenderian SS, He R, Leis JF, Shi M, Van Dyke DL, Kay NE, Slager SL, Braggio E, Yan H, Ding W. Differential transcriptomic profiling in ibrutinib-naive versus ibrutinib-resistant Richter syndrome. Hematol Oncol 2022 Apr; 40 (2):302-306 Epub 2021 Dec 03
    View PubMed
  11. Koleilat A, McGarrah PW, Olteanu H, Van Dyke DL, Smadbeck JB, Johnson SH, Vasmatzis G, Hoppman NL, Xu X, Ketterling RP, Greipp PT, Baughn LB, Patnaik MS, Peterson JF. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions. Cancer Genet. 2022 Jan; 260-261:1-5 Epub 2021 Nov 06
    View PubMed
  12. Wu X, Nowakowski KE, Abeykoon JP, Manske M, Stenson MJ, Timm MM, Hanson CA, Van Dyke DL, Dasari S, Witzig TE. MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance. Eur J Haematol. 2021 Oct; 107 (4):458-465 Epub 2021 July 18
    View PubMed
  13. Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Leis JF, Kenderian SS, Muchtar E, Wang Y, Koehler AB, Schwager SM, Lesnick CE, Kleinstern G, Van Dyke D, Hanson CA, Braggio E, Slager SL, Shanafelt TD. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. Blood. 2021 Jul 15; 138 (2):149-159
    View PubMed
  14. Audil HY, Hampel PJ, Van Dyke DL, Achenbach SJ, Rabe KG, Smoley SA, Call TG, Ding W, Shi M, Hanson CA, Wang Y, Muchtar E, Koehler AB, Schwager SM, Leis JF, Braggio E, Slager SL, Kay NE, Kenderian SS, Parikh SA. The prognostic significance of del6q23 in chronic lymphocytic leukemia. Am J Hematol 2021 Jun 1; 96 (6):E203-E206 Epub 2021 Apr 07
    View PubMed
  15. Wang Y, Sinha S, Wellik LE, Secreto CR, Rech KL, Call TG, Parikh SA, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Van Dyke DL, Leis JF, Slager SL, Dong H, Kay NE, He R, Ding W. Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome. Blood Cancer J. 2021 May 10; 11 (5):86
    View PubMed
  16. Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia. Blood Cancer J 2021 Mar 2; 11 (3):47 Epub 2021 Mar 02
    View PubMed
  17. Larson DP, Akkari YM, Van Dyke DL, Raca G, Gardner JA, Rehder CW, Kaiser-Rogers KA, Eagle P, Yuhas JA, Gu J, Toydemir RM, Kearney H, Conlin LK, Tang G, Dolan MM, Ketterling RP, Peterson JF. Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee. Arch Pathol Lab Med. 2021 Feb 1; 145 (2):176-190
    View PubMed
  18. Hampel PJ, Call TG, Rabe KG, Ding W, Muchtar E, Kenderian SS, Wang Y, Leis JF, Witzig TE, Koehler AB, Fonder AL, Schwager SM, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia. Oncologist. 2020 Nov; 25 (11):974-980 Epub 2020 Sept 20
    View PubMed
  19. Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01
    View PubMed
  20. Gupta S, Inwards CY, Van Dyke DL, Jimenez RE, Cheville JC. Defining clear cell papillary renal cell carcinoma in routine clinical practice. Histopathology 2020 Jun; 76 (7):1093-1095 Epub 2020 May 07
    View PubMed
  21. Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF, Kenderian SS, Kay NE, Muchtar E, Van Dyke DL, Koehler AB, Schwager SM, Slager SL, Parikh SA, Ding W. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center. Haematologica. 2020 Mar; 105 (3):765-773 Epub 2019 June 13
    View PubMed
  22. Hampel PJ, Call TG, Ding W, Muchtar E, Kenderian SS, Wang Y, Leis JF, Witzig TE, Koehler AB, Fonder AL, Schwager SM, Rabe KG, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Am J Hematol 2020 Mar; 95 (3):E57-E60 Epub 2019 Dec 13
    View PubMed
  23. Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica. 2020 Jan 23 [Epub ahead of print]
    View PubMed
  24. Zhang D, Liao X, Tang Y, Meyer RG, VAN Dyke DL, Liu X, Islam MN, Lai J. Warthin-like Mucoepidermoid Carcinoma of the Parotid Gland: Unusual Morphology and Diagnostic Pitfalls. Anticancer Res. 2019 Jun; 39 (6):3213-3217
    View PubMed
  25. Fang H, Reichard KK, Rabe KG, Hanson CA, Call TG, Ding W, Kenderian SS, Muchtar E, Schwager SM, Leis JF, Chanan-Khan AA, Slager SL, Braggio E, Smoley SA, Kay NE, Shanafelt TD, Van Dyke DL, Parikh SA. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes. Am J Hematol. 2019 Mar; 94 (3):338-345 Epub 2019 Jan 08
    View PubMed
  26. Peterson JF, Rowsey RA, Marcou CA, Pearce KE, Williamson CM, Frederick LA, Greipp PT, Ketterling RP, Kumar S, Viswanatha DS, Polley MY, Fink JM, Reichard KK, Van Dyke DL, Baughn LB. Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations. Blood Cancer J 2019 Feb 19; 9 (3):20
    View PubMed
  27. Aypar U, Smoley SA, Pitel BA, Pearce KE, Zenka RM, Vasmatzis G, Johnson SH, Smadbeck JB, Peterson JF, Geiersbach KB, Van Dyke DL, Thorland EC, Jenkins RB, Ketterling RP, Greipp PT, Kearney HM, Hoppman NL, Baughn LB. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia. Eur J Haematol. 2019 Jan; 102 (1):87-96 Epub 2018 Nov 22
    View PubMed
  28. Meyer RG, Van Dyke DL. Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization. Methods Mol Biol. 2019; 1881:35-49
    View PubMed
  29. Chun K, Wenger GD, Chaubey A, Dash DP, Kanagal-Shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genet. 2018 Dec; 228-229:236-250 Epub 2018 Oct 16
    View PubMed
  30. Peterson JF, Van Dyke DL, Hoppman NL, Kearney HM, Sukov WR, Greipp PT, Ketterling RP, Baughn LB. The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review. Am J Clin Pathol. 2018 Oct 1; 150 (5):375-384
    View PubMed
  31. Fang H, Ketterling RP, Hanson CA, Pardanani A, Kurtin PJ, Chen D, Greipp PT, Howard MT, King RL, Van Dyke DL, Reichard KK. A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience. Am J Clin Pathol. 2018 Oct 1; 150 (5):421-431
    View PubMed
  32. He R, Ding W, Viswanatha DS, Chen D, Shi M, Van Dyke D, Tian S, Dao LN, Parikh SA, Shanafelt TD, Call TG, Ansell SM, Leis JF, Mai M, Hanson CA, Rech KL. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness. Am J Surg Pathol. 2018 Jul; 42 (7):843-854
    View PubMed
  33. Swanson AA, Giannini C, Folpe AL, Van Dyke DL, Amrami KK, Michalak WA, Vaubel RA. Low-grade fibromyxoid sarcoma arising within the median nerve. Neuropathology. 2018 Jun; 38 (3):309-314 Epub 2018 Jan 03
    View PubMed
  34. Babu R, Van Dyke DL, Bhattacharya S, Dev VG, Liu M, Kwon M, Gu G, Koduru P, Rao N, Williamson C, Fuentes E, Fuentes S, Papa S, Kopuri S, Lal V. A rapid and reliable chromosome analysis method for products of conception using interphase nuclei. Mol Genet Genomic Med. 2018 May; 6 (3):370-381 Epub 2018 Mar 24
    View PubMed
  35. Babu R, Van Dyke DL, Dev VG, Koduru P, Rao N, Mitter NS, Liu M, Fuentes E, Fuentes S, Papa S. Interphase Chromosome Profiling: A Method for Conventional Banded Chromosome Analysis Using Interphase Nuclei. Arch Pathol Lab Med. 2018 Feb; 142 (2):213-228 Epub 2017 Oct 05
    View PubMed
  36. Hammond WA, Advani P, Ketterling RP, Van Dyke D, Foran JM, Jiang L. Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia. Case Rep Hematol. 2018; 2018:7456378 Epub 2018 July 24
    View PubMed
  37. Dias A, Al-Kali A, Van Dyke D, Niederwieser D, Vucinic V, Lemke J, Muller C, Schwind S, Teichmann AC, Bakken R, Burns LJ, Litzow M. Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality. Biol Blood Marrow Transplant. 2017 Sep; 23 (9):1582-1587 Epub 2017 May 23
    View PubMed
  38. Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017 Jun 29; 129 (26):3419-3427 Epub 2017 Apr 19
    View PubMed
  39. Bieber FR, Cherry AM, Emanuel BS, Francke U, Hoyme HE, Jackson LG, Morton CC, Muenke M, Powell CM, Punnett HH, Rao PN, Schwartz S, Stevenson RE, Van Dyke DL. Commentary on the decision of the American Board of Medical Genetics and Genomics to create a 24-month specialty of Laboratory Genetics and Genomics. Genet Med 2017 Mar; 19 (3):294-296 Epub 2016 Nov 17
    View PubMed
  40. He R, Wiktor AE, Durnick DK, Kurtin PJ, Van Dyke DL, Tefferi A, Patnaik MS, Ketterling RP, Hanson CA. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes. Am J Clin Pathol. 2016 Jul; 146 (1):86-94 Epub 2016 June 27
    View PubMed
  41. Van Dyke DL, Werner L, Rassenti LZ, Neuberg D, Ghia E, Heerema NA, Dal Cin P, Dell Aquila M, Sreekantaiah C, Greaves AW, Kipps TJ, Kay NE. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience. Br J Haematol. 2016 Apr; 173 (1):105-13 Epub 2016 Feb 05
    View PubMed
  42. Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W, Chanan-Khan AA, Bowen D, Conte M, Schwager S, Slager SL, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes. Cancer. 2015 Sep 1; 121 (17):2883-91 Epub 2015 Apr 30
    View PubMed
  43. He R, Wiktor AE, Hanson CA, Ketterling RP, Kurtin PJ, Van Dyke DL, Litzow MR, Howard MT, Reichard KK. Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia. Am J Clin Pathol. 2015 Jun; 143 (6):873-8
    View PubMed
  44. Ojha J, Secreto CR, Rabe KG, Van Dyke DL, Kortum KM, Slager SL, Shanafelt TD, Fonseca R, Kay NE, Braggio E. Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia. Br J Haematol 2015 May; 169 (3):445-8 Epub 2014 Nov 10
    View PubMed
  45. Ojha J, Ayres J, Secreto C, Tschumper R, Rabe K, Van Dyke D, Slager S, Shanafelt T, Fonseca R, Kay NE, Braggio E. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood. 2015 Jan 15; 125 (3):492-8 Epub 2014 Nov 06
    View PubMed
  46. Aypar U, Reichard KK, Waltman LA, Van Dyke DL. Isolated trisomy 2 in bone marrows of patients with suspected hematopoietic malignancies. Cancer Genet. 2014 Apr; 207: (4)124-7.
    View PubMed
  47. Geiersbach KB, Gardiner AE, Wilson A, Shetty S, Bruyere H, Zabawski J, Saxe DF, Gaulin R, Williamson C, Van Dyke DL. Subjectivity in chromosome band-level estimation: a multicenter study. Genet Med. 2014 Feb; 16 (2):170-5 Epub 2013 July 25
    View PubMed
  48. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol. 2013 Nov; 163(3):326-33. Epub 2013 Aug 27.
    View PubMed
  49. Waltman LA, Eckel-Passow JE, Sharma RG, Van Dyke DL. Advanced maternal age in polyploidy with concurrent aneuploidy. Am J Med Genet A. 2013 May; 161A(5):1200-2. Epub 2013 Mar 29.
    View PubMed
  50. Crotti L, Tester DJ, White WM, Bartos DC, Insolia R, Besana A, Kunic JD, Will ML, Velasco EJ, Bair JJ, Ghidoni A, Cetin I, Van Dyke DL, Wick MJ, Brost B, Delisle BP, Facchinetti F, George AL, Schwartz PJ, Ackerman MJ. Long QT syndrome-associated mutations in intrauterine fetal death. JAMA. 2013 Apr 10; 309(14):1473-82.
    View PubMed
  51. Hutchens C, Ketterling RP, Van Dyke. When are apparently non-clonal abnormalities in bone marrow chromosome studies actually clonal? Cancer Genet. 2012 Jul-Aug; 205(7-8):405-9.
    View PubMed
  52. Cherry AM, Slovak ML, Campbell LJ, Chun K, Eclache V, Haase D, Haferlach C, Hildebrandt B, Iqbal AM, Jhanwar SC, Ohyashiki K, Sole F, Vandenberghe P, VanDyke DL, Zhang Y, Dewald GW. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia? Leuk Res. 2012 Jul; 36(7):832-40. Epub 2012 Apr 25.
    View PubMed
  53. Hussain FT, Nguyen EP, Raza S, Knudson R, Pardanani A, Hanson CA, Van Dyke, Tefferi A. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications. Am J Hematol. 2012 Jul; 87(7):684-6. Epub 2012 May 06.
    View PubMed
  54. Braggio E, Kay N, Van Wier S, Tschumper RC, Smoley SA, Eckel-Passow JE, Sassoon T, Van Dyke DL, Byrd JC, Jelinek DF, Shanafelt TD, Fonseca R. Longitudinal genome wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Blood. 2011 Nov 18; 118(21):1223-4.
  55. Hofherr SE, Wiktor AE, Kipp BR, Dawson DB, Van Dyke DL. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet. 2011 Nov; 28 (11):1091-8 Epub 2011 Sept 13
    View PubMed
  56. Tefferi A, Jimma T, Gangat N, Vaidya R, Begna KH, Hanson CA, Van Dyke DL, Caramazza D, Pardanani A. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients. Blood. 2011 Oct 27; 118 (17):4595-8 Epub 2011 Aug 31
    View PubMed
  57. Wiktor AE, Van Dyke DL, Hodnefield JM, Eckel-Passow J, Hanson CA. The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 years. Leuk Res. 2011 Oct; 35 (10):1297-300 Epub 2011 June 23
    View PubMed
  58. Brothman AR, Dolan MM, Goodman BK, Park JP, Persons DL, Saxe DF, Tepperberg JH, Tsuchiya KD, Van Dyke DL, Wilson KS, Wolff DJ, Theil KS. College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med. 2011 Sep; 13(9):765-9.
    View PubMed
  59. Vaidya R, Caramazza D, Begna KH, Gangat N, Van Dyke DL, Hanson CA, Pardanani A, Tefferi A. Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival. Blood. 2011 May 26; 117 (21):5612-5 Epub 2011 Mar 30
    View PubMed
  60. Raza S, TaherNazerHussain F, Patnaik M, Knudson R, Van Dyke, Tefferi A. Autosomal monosomies among 24,262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities. Am J Hematol. 2011 Apr; 86(4):353-6.
    View PubMed
  61. Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke D, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011 Feb 1; 29 (4):392-7 Epub 2010 Dec 13
    View PubMed
  62. Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia. 2011 Feb; 25(2):266-70. Epub 2010 Nov 12.
    View PubMed
  63. Wang RW, Olson RM, Spurbeck JL, Bertling KM, Mitchell EB, Van Dyke DL. ISCN (2009)-A Reference Guide. J Assoc Genet Technol. 2011; 37(2):85-94.
  64. Caramazza D, Begna KH, Gangat N, Vaidya R, Siragusa S, Van Dyke, Hanson C, Pardanani A, Tefferi A. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia. 2011 Jan; 25(1):82-8. Epub 2010 Oct 14.
    View PubMed
  65. Kay NE, Eckel-Passow JE, Braggio E, Vanwier S, Shanafelt TD, Van Dyke DL, Jelinek DF, Tschumper RC, Kipps T, Byrd JC, Fonseca R. Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genet Cytogenet. 2010 Dec; 203 (2):161-8
    View PubMed
  66. Smoley SA, Van Dyke DL, Kay NE, Heerema NA, Dell' Aquila ML, Dal Cin P, Koduru P, Aviram A, Rassenti L, Byrd JC, Rai KR, Brown JR, Greaves AW, Eckel-Passow J, Neuberg D, Kipps TJ, Dewald GW. Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. Cancer Genet Cytogenet. 2010 Dec; 203(2):141-8.
    View PubMed
  67. Heerema NA, Byrd JC, Dal Cin, Dell' Aquila, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study. Cancer Genet Cytogenet. 2010 Dec; 203(2):134-40.
    View PubMed
  68. Sukov WR, Ketterling RP, Wei S, Monaghan K, Blunden P, Mazzara P, Raghavan R, Oliviera AM, Wiktor AE, Keeney GL, Van Dyke. Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor. Cancer Genet Cytogenet. 2010 Oct 15; 202(2):123-8.
    View PubMed
  69. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol. 2010 Feb; 148 (4):544-50 Epub 2009 Nov 06
    View PubMed
  70. Hussein K, Pardanani AD, Van Dyke DL, Hanson CA, Tefferi A. International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis. Blood. 2010 Jan 21; 115 (3):496-9 Epub 2009 Nov 09
    View PubMed
  71. Wolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee. Laboratory guideline for Turner syndrome. Genet Med. 2010 Jan; 12(1):52-5.
    View PubMed
  72. Deng XX, Nguyen DK, Hansen RS, Van Dyke DL, Gartler SM, Disteche CM. Dosage regulation of the active X chromosome in human triploid cells. PLoS Genet. 2009 Dec; 5(12).
  73. Dewald GW, Smyrk TC, Thorland EC, McWilliams RR, Van Dyke DL, Keefe JG, Belongie KJ, Smoley SA, Knutson DL, Fink SR, Wiktor AE, Petersen GM. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. Mayo Clin Proc. 2009 Sep; 84 (9):801-10
    View PubMed
  74. Tam CS, Shanafelt TD, Wierda WG, Abruzzo LV, Van Dyke DL, O'Brien S, Ferrajoli A, Lerner SA, Lynn A, Kay NE, Keating MJ. De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience. Blood. 2009 Jul 30; 114(5):957-64. Epub 2009 May 4
    View PubMed
  75. Fink SR, Belongie KJ, Paternoster SF, Smoley SA, Pardanani AD, Tefferi A, Van Dyke DL, Ketterling RP. Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations. Leuk Res. 2009 Jun; 33 (6):843-6 Epub 2008 Dec 31
    View PubMed
  76. Hussein K, Van Dyke DL, Tefferi A. Conventional cytogenetics in myelofibrosis: literature review and discussion. Eur J Haematol. 2009 May; 82(5):329-38. Epub 2009 Jan 9
    View PubMed
  77. Hussein K, Huang J, Lasho T, Pardanani A, Mesa RA, Williamson CM, Ketterling RP, Hanson CA, Van Dyke DL, Tefferi A. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis. Eur J Haematol. 2009 Apr; 82(4):255-9. Epub 2008 Feb 10
    View PubMed
  78. Wiktor AE, Bender G, Van Dyke DL. Identification of sex chromosome mosaicism: is analysis of 20 metaphase cells sufficient? Am J Med Genet A. 2009 Feb; 149A (2):257-9
    View PubMed
  79. Hussein K, Ketterling RP, Dewald GW, Van Dyke DL, Mesa R, Hanson CA, Tefferi A. Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies. Leuk Res. 2008 Oct; 32(10):1597-600. Epub 2008 Feb 1
    View PubMed
  80. Hussein K, Ketterling RP, Hulshizer RL, Kuffel DG, Wiktor AE, Hanson CA, Tefferi A, Van Dyke DL. Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis. Eur J Haematol. 2008 Apr; 80(4):318-21. Epub 2007 Dec 18
    View PubMed
  81. Hanson CA, Steensma DP, Hodnefield JM, Nguyen PL, Hoyer JD, Viswanatha DS, Zou Y, Knudson RA, Van Dyke DL, Ketterling RP. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol. 2008 Mar; 129(3):478-85.
    View PubMed
  82. Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leuk Lymphoma. 2007 Dec; 48 (12):2412-7
    View PubMed
  83. Adeyinka A, Smoley S, Fink S, Sanchez J, Van Dyke DL, Dewald G. Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns. Cancer Genet Cytogenet. 2007 Nov; 179(1):25-30.
    View PubMed
  84. Ida CM, Rolig KA, Hulshizer RL, Van Dyke DL, Randolph JL, Jenkins RB, Nascimento AG, Oliveira AM. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality. Cancer Genet Cytogenet. 2007 Sep; 177(2):139-42.
    View PubMed
  85. Micale MA, Schran D, Emch S, Kurczynski TW, Rahman N, Van Dyke DL. Mosaic variegated aneuploidy without microcephaly: Implications for cytogenetic diagnosis. Am J Med Genet A. 2007 Aug 15; 143A(16):1890-3.
  86. Zou YS, Van Dyke DL, Ellison JW. Microarray comparative genomic hybridization and FISH studies of an unbalanced cryptic telomeric 2p deletion/16q duplication in a patient with mental retardation and behavioral problems. Am J Med Genet A. 2007 Apr 1; 143A (7):746-51
    View PubMed
  87. Graf MD, Christ L, Mascarello JT, Mowrey P, Pettenati M, Stetten G, Storto P, Surti U, Van Dyke DL, Vance GH, Wolff D, Schwartz S. Redefining the risks of prenatally ascertained supernumerary marker chromosomes: a collaborative study. J Med Genet. 2006 Aug; 43(8):660-4.
    View PubMed
  88. Zou YS, Van Dyke DL, Thorland EC, Chhabra HS, Michels VV, Keefe JG, Lega MA, Feely MA, Uphoff TS, Jalal SM. Mosaic ring 20 with no detectable deletion by FISH analysis: Characteristic seizure disorder and literature review. Am J Med Genet A. 2006 Aug 01; 140(15):1696-706.
    View PubMed
  89. Zou YS, McGrann PS, Uphoff TS, Van Dyke DL. A case of mosaic supernumerary ring chromosome 15 with two copies of the segment 15p11.1-q14. Am J Med Genet A. 2006 Aug 1; 140 (15):1663-8
    View PubMed
  90. Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW. Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Jun; 167(2):177-81.
    View PubMed
  91. Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Apr 15; 166(2):152-6.
    View PubMed
  92. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med. 2006 Jan; 8 (1):16-23
    View PubMed
  93. Wiktor AE, Stupca PJ, Van Dyke DL. USCN(2005) - A Reference Guide. J Assoc Genet Technol. 2006; 32(2):32-40.
  94. Welch RA, Salem-Elgharib S, Wiktor AE, Van Dyke DL, Blessed WB. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol. 2006 Jan; 194(1):189-91.
    View PubMed
  95. Dewald GW, Therneau T, Larson D, Lee YK, Fink S, Smoley S, Paternoster S, Adeyinka A, Ketterling R, Van Dyke DL, Fonseca R, Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood. 2005 Nov 15; 106 (10):3553-8 Epub 2005 July 19
    View PubMed
  96. Wiktor AE, Van Dyke DL. Detection of low level sex chromosome mosaicism in Ullrich-Turner syndrome patients. Am J Med Genet A. 2005 Oct 15; 138A (3):259-61
    View PubMed
  97. Wiktor AE, Van Dyke DL. Detection of low level sex chromosome mosaicism in Ullrich-Turner syndrome patients. Am J Med Genet Part A. 2005 Oct 15; 138A(3):259-61.
  98. Adeyinka A, Adams SA, Lorentz CP, Van Dyke DL, Jalal SM. Subtelomere deletions and translocations are frequently familial. Am J Med Genet A. 2005 May 15; 135 (1):28-35
    View PubMed
  99. Adeyinka A, Adams SA, Lorentz CP, Van Dyke DL, Jalal SM. Subtelomere deletions and translocations are frequently familial. Am J Med Genet Part A. 2005 May 15; 135A(1):28-35.
  100. Caudill SP, Van Dyke DL, Chen AT, Reidy JA, Ing PS, Schwartz S, Vance GH. Evaluating current policy for detecting mosaicism in amniotic fluid cultures: implications for current cell counting practices. Stat Med. 2005 Feb 28; 24(4):615-22.
    View PubMed
  101. Coon SW, Savera AT, Zarbo RJ, Benninger MS, Chase GA, Rybicki BA, Van Dyke DL. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int J Cancer. 2004 Aug 20; 111(2):206-12.
    View PubMed
  102. Wiktor A, Van Dyke DL. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma. Cancer Genet Cytogenet. 2004 Aug; 153(1):73-6.
    View PubMed
  103. Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL, Wiktor A, Rowley JD. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chrom Cancer. 2004 Aug; 40(4):365-70.
    View PubMed
  104. Asamoah A, Nwankwo M, Kumar SP, Ezhuthachan SG, Van Dyke DL. Proximal chromosome 8q deletion in a boy with femoral bifurcation and other multiple congenital anomalies. Am J Med Genet Part A. 2004 May 15; 127(1):65-8.
    View PubMed
  105. Wiktor A, Van Dyke DL. FISH analysis helps identify low-level mosaicism in Ullrich-Turner syndrome patients. Genet Med. 2004 May-Jun; 6(3):132-5.
    View PubMed
  106. Kuriakose P, Perveen N, Maeda K, Wiktor A, Van Dyke DL. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 2004 Apr 15; 150(2):156-8.
    View PubMed
  107. Raitanen M, Worsham MJ, Lakkala T, Carey TE, Van Dyke DL, Grenman R, Klemi P, Rantanen V, Isola J, Grenman S. Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry. Gynecol Oncol. 2004 Apr; 93(1):155-63.
    View PubMed
  108. Salama ME, Shah V, Lebel RR, VanDyke DL. Aberrant nuclear projections of neutrophils in trisomy 13. Arch Path Lab Med. 2004 Feb; 128(2):243-4.
    View PubMed
  109. Rybicki BA, Savera AT, Gomez JA, Patel SC, Ballard NE, Benninger MS, Zarbo RJ, Van Dyke DL. Allelic loss and tumor pathology in head and neck squamous cell carcinoma. Mod Pathol. 2003 Oct; 16(10):970-9.
    View PubMed
  110. Van Dyke DL, Wiktor A. Monosomy 21 in hematologic diseases. Cancer Genet Cytogenet. 2003 Apr 15; 142(2):137-41.
    View PubMed
  111. Asamoah A, Decker AB, Wiktor A, Van Dyke DL. Child with De Novo t(1;6)(p22.1;p22.1) translocation and features of ectodermal dysplasia with hypodontia and developmental delay. Am J Med Genet Part A. 2003 Apr 1; 118(1):82-5.
    View PubMed
  112. Wiktor A, Linden MD, Van Dyke DL. HER-2/neu testing in breast cancer. J Assoc Genet Technol. 2003; 29:152-5.
  113. Monaghan KG, Wiktor A, Van Dyke DL. Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison. Genet Med. 2002 Nov-Dec; 4(6):448-50.
    View PubMed
  114. Wilson SC, Susman M, Bain S, Wohlferd M, Van Dyke DL, Daniel A, White B, Gardner RJ. Isochromosome 5p mosaicism at prenatal diagnosis: observations and outcomes in six cases at chorionic villus sampling and one at amniocentesis. Prenat Diagn. 2002 Aug; 22(8):681-5.
    View PubMed
  115. Satinover DL, Vance GH, Van Dyke DL, Schwartz S. Cytogenetic analysis and construction of a BAC contig across a common neocentromeric region from 9p. Chromosoma. 2001 Aug; 110(4):275-83.
    View PubMed
  116. Wiktor A, Feldman GL, Bawle EV, Czarnecki P, Conard JV, Van Dyke DL. Deletion of 2q37 and duplication of 10q24: two cases in the same family and review of the literature. Ann Genet. 2001 Jul-Sep; 44(3):129-34.
    View PubMed
  117. Barnabas N, Shurafa M, Van Dyke DL, Wolman SR, Clark D, Worsham MJ. Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients. Cancer. 2001 Jan 15; 91(2):285-93.
    View PubMed
  118. Manji S, Roberson JR, Wiktor A, Vats S, Rush P, Diment S, Van Dyke DL. Prenatal diagnosis of 22q11.2 deletion when ultrasound examination reveals a heart defect. Genet Med. 2001 Jan-Feb; 3(1):65-6.
    View PubMed
  119. Teshima I, Bawle EV, Weksberg R, Shuman C, Van Dyke DL, Schwartz S. Analphoid 3qter markers. Am J Med Genet. 2000 Sep 11; 94(2):113-9.
    View PubMed
  120. Baumgartner BJ, Shurafa M, Terebelo H, Tapazoglou E, Van Dyke DL. Trisomy 15, sex chromosome loss, and hematological malignancy. Cancer Genet Cytogenet. 2000 Mar; 117(2):132-5.
    View PubMed
  121. Wallerstein R, Yu MT, Neu RL, Benn P, Lee Bowen C, Crandall B, Disteche C, Donahue R, Harrison B, Hershey D, Higgins RR, Jenkins LS, Jackson-Cook C, Keitges E, Khodr G, Lin CC, Luthardt FW, Meisner L, Mengden G, Patil SR, Rodriguez M, Sciorra LJ, Shaffer LG, Stetten G, Van Dyke DL, Wang H. Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations. Prenat Diagn. 2000 Feb; 20(2):103-22.
    View PubMed
  122. Wiktor A, Rybicki BA, Piao ZS, Shurafa M, Barthel B, Maeda K, Van Dyke DL. Clinical significance of Y chromosome loss in hematologic disease. Genes Chrom Cancer. 2000 Jan; 27(1):11-6.
    View PubMed
  123. Ing PS, Van Dyke DL, Caudill SP, Reidy JA, Bice G, Bieber FR, Buchanan PD, Carroll AJ, Cheung SW, DeWald G, Donahue RP, Gardner HA, Higgins J, Hsu LYF, Jamehdor M, Keitges EA, Laundon CH, Luthardt FW, Mascarello J, May KM, Meck JM, Morton C, Patil S, Peakman D, Pettenati MJ, Chen ATL, et al. Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study. Genet Med. 1999 Mar-Apr; 1(3):94-7.
    View PubMed
  124. Tsai CH, Van Dyke DL, Feldman GL. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Am J Med Genet. 1999 Feb 12; 82(4):336-9.
    View PubMed
  125. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. Mol Pathol. 1999 Feb; 52(1):42-6.
    View PubMed
  126. Berend SA, Feldman GL, McCaskill C, Czarnecki P, Van Dyke DL, Shaffer LG. Investigation of two cases of paternal disomy 13 suggests timing of isochromosome formation and mechanisms leading to uniparental disomy. Am J Med Genet. 1999 Jan 29; 82(3):275-81.
    View PubMed
  127. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL, Ross JL. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet. 1998 Dec; 63(6):1757-66.
    View PubMed
  128. Monaghan KG, Van Dyke DL, Feldman GL. Prader-Willi-like syndrome in a patient with an Xq23q25 duplication. Am J Med Genet. 1998 Nov 16; 80(3):227-31.
    View PubMed
  129. Pratt VM, Roberson JR, Weiss L, Van Dyke DL. Duplication 6q21q23 in two unrelated patients. Am J Med Genet. 1998 Nov 2; 80(2):112-4.
    View PubMed
  130. Wiktor A, Puskorius R, Zubrickas K, Van Dyke DL. Sequential G-banding and fluorescent in situ hybridization on peripheral blood, bone marrow, and amniotic fluid samples. Am J Med Genet. 1998 Aug 27; 79(1):38-41.
    View PubMed
  131. White WM, Willard HF, Van Dyke DL, Wolff DJ. The spreading of X inactivation into autosomal material of an x;autosome translocation: evidence for a difference between autosomal and X-chromosomal DNA.[erratum appears in Am J Hum Genet 1998 Oct;63(4):1252]. Am J Hum Genet. 1998 Jul; 63(1):20-8.
    View PubMed
  132. Monaghan KG, Dennehy PJ, VanDyke DL, Weiss L. Bilateral Peter's anomaly in an infant with 49,XXXXY syndrome. J Pediatr Ophthalmol Strabismus. 1998 Mar-Apr; 35(2):112-3.
    View PubMed
  133. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA, Van Dyke DL. Loss of 18q predicts poor survival in patients with squamous cell carcinoma of the head and neck. Genes Chromosomes & Cancer. 1998; 21:333-9.
    View PubMed
  134. Monaghan KG, Van Dyke DL, Wiktor A, Feldman GL. Cytogenetic and clinical findings in a patient with a deletion of 16q23.1: first report of bilateral cataracts and a 16q deletion. Am J Med Genet. 1997 Dec 12; 73(2):180-3.
    View PubMed
  135. Depinet TW, Zackowski JL, Earnshaw WC, Kaffe S, Sekhon GS, Stallard R, Sullivan BA, Vance GH, Van Dyke DL, Willard HF, Zinn AB, Schwartz S. Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA. Hum Mol Genet. 1997 Aug; 6(8):1195-204.
    View PubMed
  136. Wolff DJ, Gustashaw KM, Zurcher V, Ko L, White W, Weiss L, Van Dyke DL, Schwartz S, Willard HF. Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern. Hum Genet. 1997 Aug; 100(2):256-61.
    View PubMed
  137. Jones JW, Raval JR, Beals TF, Worsham MJ, Van Dyke DL, Esclamado RM, Wolf GT, Bradford CR, Miller T, Carey TE. Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23. Arch Otolaryngol Head Neck Surg. 1997 Jun; 123(6):610-4.
    View PubMed
  138. Hsu LY, Yu MT, Neu RL, Van Dyke DL, Benn PA, Bradshaw CL, Shaffer LG, Higgins RR, Khodr GS, Morton CC, Wang H, Brothman AR, Chadwick D, Disteche CM, Jenkins LS, Kalousek DK, Pantzar TJ, Wyatt P. Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: karyotype/phenotype correlations. Prenat Diagn. 1997 Mar; 17(3):201-42.
    View PubMed
  139. Carey TE, Frank CJ, Raval JR, Jones JW, McClatchey KD, Beals TF, Worsham MJ, Van Dyke DL. Identifying genetic changes associated with tumor progression in squamous cell carcinoma. Acta Otolaryngol Suppl (Stockh). 1997; 529: 229-32.
    View PubMed
  140. Pearlstein RP, Benninger MS, Rybicki BA, Torres F, Van Dyke DL. Preliminary study of 18q loss of heterozygosity and poor survival in patients with stage III head and neck cancer. On-line Interact J Otolaryngol II: FA: 1997; 1-6.
  141. Kelker W, Van Dyke DL, Worsham MJ, Christopherson PL, James CD, Conlon MR, Carey TE. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res. 1996 Jul-Aug; 16(4C):2365-72.
    View PubMed
  142. Buchagen DL, Worsham MJ, Van Dyke DL, Carey TE. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: Comparison with cytogenetic analysis. Head and Neck. 1996; 18:529-537.
    View PubMed
  143. Hsu LY, Yu MT, Richkind KE, Van Dyke DL, Crandall BF, Saxe DF, Khodr GS, Mennuti M, Stetten G, Miller WA, Priest JH. Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality diagnosed prenatally through amniocentesis: a collaborative study. Prenat Diagn. 1996 Jan; 16(1):1-28.
    View PubMed
  144. Wolff DJ, Miller AP, Van Dyke DL, Schwartz S, Willard HF. Molecular definition of breakpoints associated with human Xq isochromosomes: implications for mechanisms of formation. Am J Hum Genet. 1996 Jan; 58(1):154-60.
    View PubMed
  145. Wiktor A, Van Dyke DL. Cytogenetics nomenclature - a reference guide. Applied Cytogenetics. 1996; 22:24-9.
  146. Bischoff FZ, Zenger-Hain J, Moses D, Van Dyke DL, Shaffer LG. Mosaicism for trisomy 12: four cases with varying outcomes. Prenat Diagn. 1995 Nov; 15(11):1017-26.
    View PubMed
  147. Scheuerle A, Zenger-Hain JL, Van Dyke DL, Ledbetter DH, Greenberg F, Shaffer LG. Replication banding and molecular studies of a mosaic, unbalanced dic(X;15)(Xpter-->Xq26.1::15p11-->15qter). Am J Med Genet. 1995 May 8; 56(4):403-8.
    View PubMed
  148. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol. 1995 Mar; 26(3):251-61.
    View PubMed
  149. Pettenati MJ, Rao PN, Grass F, Rao KW, Phelan MC, Cosper P, Carroll A, Elder F, Smith J, Higgins MD, Lanman JT, Higgins R, Butler M, Luthardt F, Keitges E, Brown J, Jackson-Cook C, Schwartz S, Van Dyke DL, Palmer CG. A review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet. 1995; 55:171-87.
    View PubMed
  150. Shaffer LG, McCaskill C, Han JY, Choo KH, Cutillo DM, Donnenfeld AE, Weiss L, Van Dyke DL. Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet. 1994 Nov; 55(5):968-74.
    View PubMed
  151. Wiktor A, Feldman GL, Kratkoczki P, Ditmars DM Jr, Van Dyke DL. 10p duplication characterized by fluorescence in situ hybridization. Am J Med Genet. 1994 Sep 1; 52(3):315-8.
    View PubMed
  152. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chrom Cancer. 1994 Mar; 9(3):192-206.
    View PubMed
  153. Migeon BR, Luo S, Stasiowski BA, Jani M, Axelman J, Van Dyke DL, Weiss L, Jacobs PA, Yang-Feng TL, Wiley JE. Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):12025-9.
    View PubMed
  154. Zenger-Hain JL, Van Dyke DL, Wiktor A, Walker H, Feldman GL. Inverted duplication of chromosome 5p14p15.3 confirmed with in situ hybridization. Am J Med Genet. 1993 Dec 1; 47(8):1198-201.
    View PubMed
  155. Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 1993 Nov-Dec; 13(6B):2561-7.
    View PubMed
  156. Zenger-Hain JL, Wiktor A, Goldman J, Van Dyke DL, Weiss L. X-inactivation pattern in an Ullrich-Turner syndrome patient with a small ring X and normal intelligence. Am J Med Genet. 1993 Sep 15; 47(4):490-3.
    View PubMed
  157. Feldman GL, Weiss L, Phelan MC, Schroer RJ, Van Dyke DL. Inverted duplication of 8p: ten new patients and review of the literature. Am J Med Genet. 1993 Sep 15; 47(4):482-6.
    View PubMed
  158. Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ, Van Dyke DL. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chrom Cancer. 1993 Jul; 7(3):158-64.
    View PubMed
  159. Zenger-Hain JL, Roberson J, Van Dyke DL, Weiss L. Interstitial deletion of chromosome 10, del(10) (q11.2q22.1) in a boy with developmental delay and multiple congenital anomalies. Am J Med Genet. 1993 Jun 1; 46(4):438-40.
    View PubMed
  160. Migeon BR, Luo S, Stasiowski BA, Jani M, Axelman J, Van Dyke DL, Weiss L, Jacobs PA, Yang-Feng TL, Wiley JE. Deficient transcription of XIST in individuals with tiny ring X chromosomes and severe phenotypes: implications for the role of XIST in X inactivation. Proc Nat Acad Sci (USA). 1993; 90: 12025-9.
  161. Wiktor A, Van Dyke DL, Weiss L. Characterization of a de novo 48,XX,+r(X),+r(17) by in situ hybridization in a patient with neurofibromatosis (NF1). Am J Med Genet. 1993 Jan 1; 45(1):22-4.
    View PubMed
  162. Carey TE, Worsham MJ, Van Dyke DL. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl. 1993; 17F:213-22.
    View PubMed
  163. Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE, Van Dyke DL. Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chromosomes Cancer. 1993 Jan; 6(1):58-60.
    View PubMed
  164. Van Dyke DL, Wiktor A, Palmer CG, Miller DA, Witt M, Babu VR, Worsham MJ, Roberson JR, Weiss L. Ullrich-Turner syndrome with a small ring X chromosome and presence of mental retardation. Am J Med Genet. 1992 Aug 1; 43(6):996-1005.
    View PubMed
  165. Falik-Borenstein TC, Pribyl TM, Pulst SM, Van Dyke DL, Weiss L, Chu ML, Kraus J, Marshak D, Korenberg JR. Stable ring chromosome 21: molecular and clinical definition of the lesion. Am J Med Genet. 1992 Jan 1; 42(1):22-8.
    View PubMed
  166. Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MP, Roberts JA, Gasser KM, Schwartz DR, Carey TE. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chrom Cancer. 1991 Nov; 3(6):420-32.
    View PubMed
  167. Bradford CR, Kimmel KA, Van Dyke DL, Worsham MJ, Tilley BJ, Burk D, del Rosario F, Lutz S, Tooley R, Hayashida DJ, et al. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody. Genes Chromosomes Cancer. 1991 Jul; 3(4):272-82.
    View PubMed
  168. Tazelaar J, Roberson J, Van Dyke DL, Babu VR, Weiss L. Mother and son with deletion of 3p25-pter. Am J Med Genet. 1991 May 1; 39(2):130-2.
    View PubMed
  169. Van Dyke DL, Wiktor A, Roberson JR, Weiss L. Mental retardation in Turner syndrome. J Pediatr. 1991 Mar; 118(3):415-7.
    View PubMed
  170. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL. Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet. 1990 Aug 1; 48(1):83-7.
    View PubMed
  171. Bodrug SE, Roberson JR, Weiss L, Ray PN, Worton RG, Van Dyke DL. Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet. 1990 Jul; 27(7):426-32.
    View PubMed
  172. Nowinski GP, Van Dyke DL, Tilley BC, Jacobsen G, Babu VR, Worsham MJ, Wilson GN, Weiss L. The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am J Hum Genet. 1990 Jun; 46(6):1101-11.
    View PubMed
  173. Grenman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grenman R, Carey TE. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer. 1990 May 15; 45(5):920-7.
    View PubMed
  174. Grenman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, Babu VR, Roberts JA, Maenpaa J, Carey TE. Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line. Gynecol Oncol. 1990 May; 37(2):188-99.
    View PubMed
  175. Raman BK, Janakiraman N, Raju UR, Carey J, Babu VR, Van Dyke DL, Van Slyck EJ. Osteomyelosclerosis with granulocytic sarcoma of chest wall. Morphological, ultrastructural, immunologic, and cytogenetic study. Arch Path Lab Med. 1990 Apr; 114(4):426-9.
    View PubMed
  176. Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, Hsu S, Baker SR. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res. 1989 Nov 1; 49(21):6098-107.
    View PubMed
  177. Robinow M, Haney N, Chen H, Sorauf T, Van Dyke DL, Babu VR, Powell S, Maliszewski W, Guerin S, Landers JW. Secondary trisomy or mosaic "tetrasomy" 8p. Am J Med Genet. 1989 Mar; 32(3):320-4.
    View PubMed
  178. Worsham MJ, Miller DA, Devries JM, Mitchell AR, Babu VR, Surli V, Weiss L, Van Dyke DL. A dicentric recombinant 9 derived from a paracentric inversion: phenotype, cytogenetics, and molecular analysis of centromeres. Am J Hum Genet. 1989 Jan; 44(1):115-23.
    View PubMed
  179. Jackson CE, Van Dyke DL, Talpos GB, Norum RA, Tashjian AH Jr. MEN-2 tumor associations suggest a linear order of specific endocrine tumor genes. Horm Metab Res Suppl. 1989; 21:9-12.
    View PubMed
  180. Grenman SE, Van Dyke DL, Worsham MJ, del Rosario F, Roberts JA, McClatchey KD, Schwartz DR, Babu VR, Carey TE. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. Cancer Res. 1988 Apr 1; 48(7):1864-73.
    View PubMed
  181. Forsythe MG, Walker H, Weiss L, Roberson JR, Worsham MJ, Babu VR, Van Dyke DL. Duplication and deletion 11q23-q24 recombinants in two offspring of an intrachromosomal insertion ("shift") carrier. Henry Ford Hosp Med J. 1988; 36(4):183-6.
    View PubMed
  182. Babu VR, Lutz MD, Miles BJ, Farah RN, Weiss L, Van Dyke DL. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res. 1987 Dec 15; 47(24 Pt 1):6800-5.
    View PubMed
  183. Van Dyke DL, Worsham M, Weiss L. The human inactivated X chromosome folds in early metaphase, prometaphase, and prophase. Hum Genet. 1987 Sep; 77(1):57-9.
    View PubMed
  184. Van Dyke DL, Babu VR, Weiss L. Parental age, and how extra isochromosomes (secondary trisomy) arise. Clin Genet. 1987 Jul; 32(1):75-9.
    View PubMed
  185. Babu VR, Van Dyke DL, Flejter WL, Jackson CE. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies. Am J Med Genet. 1987 Jul; 27(3):739-48.
    View PubMed
  186. Kurtzman DN, Van Dyke DL, Rich CA, Weiss L. Duplication 3p21----3pter and cyclopia. Am J Med Genet. 1987 May; 27(1):33-7.
    View PubMed
  187. Gaba AR, Van Dyke DL, Weiss L. Dysgenetic male pseudohermaphroditism in a 45,X/46,X,del(Y)(q11.1) mosaic infant. Am J Med Genet. 1987 Mar; 26(3):545-9.
    View PubMed
  188. Stoffer SS, Van Dyke DL, Bach JV, Szpunar W, Weiss L. Familial papillary carcinoma of the thyroid. Am J Med Genet. 1986 Dec; 25(4):775-82.
    View PubMed
  189. Flejter WL, Van Dyke DL, Weiss L. Location of the X inactivation center in primates and other mammals. Hum Genet. 1986 Sep; 74(1):63-6.
    View PubMed
  190. Maeda K, Hawkins ET, Oh HK, Kini SR, Van Dyke DL. Malignant lymphoma in transplanted renal pelvis. Arch Path Lab Med. 1986 Jul; 110(7):626-9.
    View PubMed
  191. Van Dyke DL, Flejter WL, Worsham MJ, Roberson JR, Higgins JV, Herr HM, Knuutila S, Wang N, Babu VR, Weiss L. A practical metaphase marker of the inactive X chromosome. Am J Hum Genet. 1986 Jul; 39(1):88-95.
    View PubMed
  192. Van Dyke DL, Worsham MJ, Fisher LJ, Weiss L. The centromere index and relative length of human high-resolution G-banded chromosomes. Hum Genet. 1986 Jun; 73(2):130-2.
    View PubMed
  193. Van Dyke DL, Weiss L. Maternal effect on intelligence in fragile X males and females. Am J Med Genet. 1986 Jan-Feb; 23(1-2):723-37.
    View PubMed
  194. Maeda K, VanSlyck EJ, VanDyke DL. Multiple myeloma terminating in acute eosinophilic leukemia. Cancer Genet Cytogenet. 1985 Mar 1; 16(1):81-9.
    View PubMed
  195. Stanley WS, Barr M Jr, Hensinger R, Ruby SG, Van Dyke DL, Weiss L. Asymmetric skeletal anomalies in siblings. Clin Genet. 1984 Jun; 25(6):533-7.
    View PubMed
  196. Babu VR, Van Dyke DL, Jackson CE. Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study. Proc Natl Acad Sci U S A. 1984 Apr; 81(8):2525-8.
    View PubMed
  197. Mu Y, Van Dyke DL, Weiss L, Olgac S. De novo direct tandem duplication of the proximal long arm of chromosome 2: 46,XX,dir dup(2)(q11 X 2q14 X 2). J Med Genet. 1984 Feb; 21(1):57-8.
    View PubMed
  198. Flejter WL, Van Dyke DL, Weiss L. Bends in human mitotic metaphase chromosomes, including a bend marking the X-inactivation center. Am J Hum Genet. 1984 Jan; 36(1):218-26.
    View PubMed
  199. Van Dyke DL, Babu VR, Jackson CE. Chromosomes in multiple endocrine neoplasia type 2 syndromes. Henry Ford Hosp Med J. 1984; 32(4):266-8.
    View PubMed
  200. Jackson CE, Van Dyke DL. Chromosome instability in medullary carcinoma of the thyroid. World J Surg. 1984; 8:491-2.
  201. Worsham MJ, Van Dyke DL. A fast and consistent C-banding technique. Mammal Chromosome Newsl. 1984; 25:69-71.
  202. Talpos GB, Jackson CE, Yott JB, Van Dyke DL. Phenotype mapping of the multiple endocrine neoplasia type II syndrome. Surgery. 1983 Oct; 94(4):650-4.
    View PubMed
  203. Van Dyke DL, Miller MJ, Weiss L. The origin of inverted tandem duplications, and phenotypic effects of tandem duplication of the X chromosome long arm. Am J Med Genet. 1983 Jul; 15(3):441-50.
    View PubMed
  204. Van Dyke DL, Weiss L, Roberson JR, Babu VR. The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet. 1983 Mar; 35(2):301-8.
    View PubMed
  205. Van Dyke DL, Weiss L, Roberson JR. The frequency of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet. 1983; 35:301-308.
  206. Haseltine FP, Lynch VA, Van Dyke DL, Breg WR, Francke U. H-Y antigen expression in patients with X-autosomal translocations and gonadal dysgenesis. Am J Med Genet. 1982 Oct; 13(2):115-23.
    View PubMed
  207. Gaba AR, Anderson GJ, VanDyke DL, Chason JL. Alobar holoprosencephaly and otocephaly in a female infant with a normal karyotype and placental villitis. J Med Genet. 1982 Feb; 19(1):78.
    View PubMed
  208. Magenis RE, Webb MJ, McKean RS, Tomar D, Allen LJ, Kammer H, Van Dyke DL, Lovrien E. Translocation(X;Y)(p22.33;p11.2) in XX males: etiology of male phenotype. Hum Genet. 1982; 62(3):271-6.
    View PubMed
  209. Van Dyke DL, Abraham JP, Maeda K, Weiss L, Poel M. Multiple active X chromosomes in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet. 1981 Mar; 3(2):137-44.
    View PubMed
  210. Melnyk AR, Weiss L, Van Dyke DL, Jarvi P. Malformation syndrome of duplication 12q24.1 leads to qter. Am J Med Genet. 1981; 10(4):357-65.
    View PubMed
  211. Lee CY, Madrazo BL, Van Dyke DL, Smith J. Prenatal diagnosis of fetal cystic hygromas associated with generalized lymphangiectasis. Henry Ford Hosp Med J. 1981; 29(2):93-6.
    View PubMed
  212. Van Dyke DL, Fluharty AL, Schafer IA, Shapiro LJ, Kihara H, Weiss L. Prenatal diagnosis of Maroteaux-Lamy syndrome. Am J Med Genet. 1981; 8(2):235-42.
    View PubMed
  213. Van Dyke DL, Weiss L, Clark J, Worsham MJ, Beisel JB. Culture and karyotyping of amniotic fluid cells. J Histotechnol. 1980; 3:148-51.
  214. Kini KR, Van Dyke DL, Weiss L, Logan MS. Ring chromosome 6: case report and review of literature. Hum Genet. 1979; 50(2):145-9.
    View PubMed
  215. Norum RA, Van Dyke DL, Weiss L. Deletion mapping of Esterase D (EsD) to chromosome 13q12.5 - q21.1. Cytogenet Cell Genet. 1979; 25:192.
  216. Klugo R, Van Dyke DL, Weiss L. Cytogenic studies of cryptorchid testes. Urology. 1978 Mar; 11(3):255-6.
    View PubMed
  217. Van Dyke DL, Palmer CG, Nance WE, Yu PL. Chromosome polymorphism and twin zygosity. Am J Hum Genet. 1977 Sep; 29(5):431-7.
    View PubMed
  218. Pai GS, Leach DC, Weiss L, Wolf C, Van Dyke DL. Thyroid abnormalities in 20 children with Turner syndrome. J Pediatr. 1977 Aug; 91(2):267-9.
    View PubMed
  219. Van Dyke DL, Weiss L, Logan M, Pai GS. The origin and behavior of two isodicentric bisatellited chromosomes. Am J Hum Genet. 1977 May; 29(3):294-300.
    View PubMed
  220. Van Dyke DL. Bibliography of human chromosome polymorphism. Mammalian Chromosome Newsletter. 1977; 18:85-119.
  221. Van Dyke DL, Bennett J. Mite elimination from stock cultures. Drosophila Inform Serv. 1971; 46:156.
  222. Bennett J, Van Dyke DL. Improved food medium. Drosophila Inform Serv. 1971; 46:160.